Changes of TGF beta 1 and TGF beta RII expression in esophageal precancerous and cancerous lesions: a study of a high-risk population in Henan, northern China
The level of transforming growth factor beta1 (TGFbeta1) and transforming growth factor betaII receptor (TGFbetaRII) was determined immunohistochemically in normal tissues and tissues with different severities of lesions (basal cell hyperplasia, BCH; dysplasia, DYS; carcinoma in situ , CIS; and squamous cell carcinoma, SCC) from surgically resected human esophagi and esophageal biopsies of symptom-free subjects. The samples were from an area with high esophageal cancer incidence in northern China (Linzhou, formerly Linxian, and nearby county Huixian in Henan Province). Peroxidase immunostain (ABC) and conventional hematoxylin and eosin stain were used. The tissue sections were incubated with antibodies of TGFbeta1 and TGFbetaRII overnight. The immunoreactivity was observed in cytoplasm of the esophageal specimen. From normal to BCH to DYS to CIS and to SCC, the positive immunostaining rates for TGFbeta1 increased significantly (P < 0.05). A linear correlation between the positive immunostaining rates of TGF beta 1 and the different lesions was observed (P < 0.05). From well- to moderately- and poorly differentiated SCC, the positive immunostaining rates for TGFbeta1 decreased gradually, but the difference was not significant (P > 0.05). In contrast, with the lesions progressing from normal to BCH to DYS to CIS and to SCC, the positive immunostaining rates for TGFbetaRII decreased significantly (P < 0.05). From well- to moderately- and poorly differentiated SCC, the positive immunostaining rates for TGF beta RII decreased significantly (P < 0.05). There was a linear correlation between the positive rates of TGFbetaRII and different lesions and SCC differentiation (P < 0.05). The present results indicated that the alterations of TGF beta 1 and TGF beta RII is a frequent event in esophageal multistage carcinogenesis, the absent or lower expression of TGF beta RII may lead to the loss of cell proliferation control by TGF beta 1 and the overexpression of TGF beta 1 may be a negative feedback response caused by the lower expression of TGF beta RII protein.
基金:
This study was supported in part by the National
Outstanding Young Scientist Award of China
30025016 (China), State Key Project for Basic
Research G1998051206 (China) and NCI CA65871
(USA).
第一作者机构:[1]Zhengzhou Univ, Coll Med, Canc Res Lab, Zhengzhou 450052, Henan, Peoples R China
通讯作者:
通讯机构:[1]Zhengzhou Univ, Coll Med, Canc Res Lab, Zhengzhou 450052, Henan, Peoples R China[2]Zhejiang Univ, Inst Canc, Hangzhou 310027, Peoples R China
推荐引用方式(GB/T 7714):
Q. Zhou,Li Dong Wang,F. Du,et al.Changes of TGF beta 1 and TGF beta RII expression in esophageal precancerous and cancerous lesions: a study of a high-risk population in Henan, northern China[J].DISEASES OF THE ESOPHAGUS.2002,15(1):74-79.doi:10.1046/j.1442-2050.2002.00227.x.
APA:
Q. Zhou,Li Dong Wang,F. Du,Y. Zhou,Y. Rui Zhang...&S. Zheng.(2002).Changes of TGF beta 1 and TGF beta RII expression in esophageal precancerous and cancerous lesions: a study of a high-risk population in Henan, northern China.DISEASES OF THE ESOPHAGUS,15,(1)
MLA:
Q. Zhou,et al."Changes of TGF beta 1 and TGF beta RII expression in esophageal precancerous and cancerous lesions: a study of a high-risk population in Henan, northern China".DISEASES OF THE ESOPHAGUS 15..1(2002):74-79